{"id":10723,"date":"2026-10-30T22:33:19","date_gmt":"2026-10-30T19:33:19","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10723"},"modified":"2026-10-30T22:33:19","modified_gmt":"2026-10-30T19:33:19","slug":"lipoproteina-management-simplified","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/lipoproteina-management-simplified\/","title":{"rendered":"Lipoprotein(a) Management Simplified"},"content":{"rendered":"<p>Lipoprotein(a) Management Simplified<\/p>\n<p>Sources: Medscape (Oct , 2026) | National Lipid Association (NLA)<\/p>\n<p>\u2022\u2060 \u2060Measure Lp(a) once in every adult.<br \/>\n\u2022\u2060 \u2060High: \u2265125 nmol\/L (\u226550 mg\/dL) \u2192 ASCVD risk enhancer; intensify LDL-C and overall risk-factor control.<br \/>\n\u2022\u2060 \u2060Statins: may slightly \u2191 Lp(a), but remain essential.<br \/>\n\u2022\u2060 \u2060PCSK9 inhibitors: \u2193 Lp(a) ~20\u201330%.<br \/>\n\u2022\u2060 \u2060Niacin: \u2193 Lp(a) ~20\u201330%, but not recommended\u2014no CV outcome benefit and more adverse effects.<br \/>\n\u2022\u2060 \u2060Pelacarsen: \u2193 Lp(a) ~80%, but did not significantly reduce MACE.<br \/>\n\u2022\u2060 \u2060Bottom line: Lowering Lp(a) does not necessarily mean better CV outcomes; treat the patient\u2019s overall ASCVD risk, not the number alone.<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"FUOMimqcf6\"><p><a href=\"https:\/\/www.lipid.org\/resource\/lipoproteina-management-simplified-the-national-lipid-association-lipid-simplified-series\/\">Lipoprotein(a) Management Simplified: The National Lipid Association Lipid Simplified Series<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u201cLipoprotein(a) Management Simplified: The National Lipid Association Lipid Simplified Series\u201d \u2014 National Lipid Association\" src=\"https:\/\/www.lipid.org\/resource\/lipoproteina-management-simplified-the-national-lipid-association-lipid-simplified-series\/embed\/#?secret=6YsrEhdviU#?secret=FUOMimqcf6\" data-secret=\"FUOMimqcf6\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lipoprotein(a) Management Simplified Sources: Medscape (Oct , 2026) | National Lipid Association (NLA) \u2022\u2060 \u2060Measure Lp(a) once in every adult. \u2022\u2060 \u2060High: \u2265125 nmol\/L (\u226550 mg\/dL) \u2192 ASCVD risk enhancer; intensify LDL-C and overall risk-factor control. \u2022\u2060 \u2060Statins: may slightly \u2191 Lp(a), but remain essential. \u2022\u2060 \u2060PCSK9 inhibitors: \u2193 Lp(a) ~20\u201330%. \u2022\u2060 \u2060Niacin: \u2193 Lp(a) [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10723","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10723"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10723\/revisions"}],"predecessor-version":[{"id":10724,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10723\/revisions\/10724"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}